Transgender Healthcare in Primary Care

Clinical Scenario

Alex Thompson, 19, a university student, calls requesting a referral to a Gender Identity Clinic to begin medical transition. He has been living as male for 12 months and has a deed poll name change. He discloses he has been self-injecting testosterone purchased online for 4 months. He also binds his chest daily and is on sertraline for depression related to gender dysphoria.

What This Case Tests

Affirming patient identity using correct name and pronouns; addressing immediate safety risks of unregulated hormone use; harm reduction approach to chest binding; initiating GIC referral with realistic waiting time counselling; managing co-existing mental health needs alongside transition support.

Common Mistakes Trainees Make

The three most common mistakes in this case are: failing to use the patient's affirmed name and pronouns from the outset (which destroys trust immediately), focusing on gatekeeping rather than harm reduction for the self-administered testosterone, and conflating gender dysphoria with the co-existing depression rather than treating them as related but distinct issues.

The Consultation Challenge

The central challenge in this case is building trust immediately through identity affirmation while simultaneously addressing a genuine clinical safety emergency. You need to balance validating the patient's autonomy with your duty of care around unregulated hormone use.

Alex has been self-injecting testosterone purchased online for four months. This is not a hypothetical risk — unmonitored testosterone can cause polycythaemia, liver dysfunction, cardiovascular events, and mood instability. The consultation tests whether you can adopt a harm reduction approach rather than a gatekeeping one. Your role is to work with the patient's reality, not to challenge their decision to transition.

The first 30 seconds are critical. If you use the wrong name or pronouns, the patient will disengage and you will lose the consultation. Check the patient record notes before speaking. Use Alex's affirmed name naturally and consistently.

The referral pathway is complex: GIC waiting times exceed 3-4 years, and Alex needs honest counselling about this. But the focus should be on what you can do now — blood tests within one week, injection safety advice, binding safety education, and maintaining mental health support alongside transition care.

Time check: Spend the first 3 minutes on identity affirmation and rapport building. By minute 5, you should have addressed the safety concern around self-administered testosterone. Use the remaining 7 minutes for the referral pathway, harm reduction planning, and mental health review.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners will assess whether you take a structured history covering the self-administered testosterone (dose, duration, source, injection technique), chest binding practices and duration, current mental health status including the interaction between gender dysphoria and depression, and the patient's support network. You must establish the presence of red flags — particularly symptoms suggesting polycythaemia or cardiovascular complications from unmonitored testosterone.

Clinical Management and Medical Complexity: This domain carries significant weight in this case. Examiners look for a clear harm reduction plan including urgent blood tests (FBC, LFTs, lipid profile, testosterone levels), safe binding advice (maximum 8-10 hours, never overnight), an immediate GIC referral with honest waiting time counselling, and a review of the sertraline in the context of ongoing transition. You need to demonstrate knowledge of the referral pathway and manage the complexity of co-existing mental health needs alongside transition support.

Relating to Others: This is where many trainees lose marks. Examiners specifically assess whether you affirm the patient's identity from the outset, demonstrate genuine empathy rather than performative tolerance, use appropriate language throughout, and create a consultation environment where the patient feels safe disclosing sensitive information. A doctor-centred or gatekeeping approach will score poorly here.

Example Opening

Strong opening: "Hello Alex, I'm Dr [Name]. Thank you for calling today — I can see from your notes you wanted to discuss something personal. I'm here to listen and help however I can. What's on your mind?"

This opening works because it uses Alex's affirmed name naturally, creates a safe space without assumptions, and invites the patient to lead the conversation on their own terms.

Avoid: "So I can see here your name has changed on the system..." (draws attention to the transition as an administrative issue rather than affirming identity).

If Alex discloses the self-administered testosterone, a strong follow-up is: "I'm really glad you've told me about that, Alex. It shows real trust, and I want to make sure we can keep you safe while we get the right support in place." This validates the disclosure without judgment while signalling your duty of care.

How This Appears in the SCA

Transgender healthcare appears under the RCGP domain of gender, reproductive and sexual health. The SCA tests your ability to provide patient-centred, non-judgmental care while managing clinical safety. Examiners assess whether you affirm identity, address harm reduction, and demonstrate awareness of referral pathways.

Key Statistic

GIC waiting times in England currently exceed 3-4 years from referral, with over 26,000 people on waiting lists as of 2024.

Relevant Guidelines

• NHS England Service Specification for Gender Identity Services
• GMC guidance on treating transgender patients
• RCGP Position Statement on transgender care in primary care.

Frequently Asked Questions

How should I address a transgender patient's name and pronouns in the SCA?

Always use the patient's affirmed name and pronouns from the first moment of the consultation. Check the patient record notes during your 3-minute reading time for preferred name and pronouns. If unsure, ask respectfully: "How would you like me to address you?" Examiners specifically assess whether you demonstrate respect for patient identity — getting this wrong in the opening seconds can undermine the entire consultation.

What are the key safety concerns with self-administered hormones?

Unregulated testosterone carries risks including polycythaemia (raised red blood cell count increasing stroke and clot risk), liver dysfunction, adverse lipid changes, mood instability, and injection site infections. Your immediate priority is harm reduction: arrange blood tests within one week (FBC, LFTs, lipid profile, testosterone levels), advise on injection site care, and discuss warning signs that require emergency attendance. Do not tell the patient to stop — work with their reality.

What is the Right to Choose pathway for GIC referrals?

The Right to Choose allows patients to access NHS-funded treatment at any provider, including private gender identity services, rather than waiting for their local GIC. In practice, this can significantly reduce waiting times from 3-4 years to months. GPs can make referrals to providers like GenderGP or London Transgender Clinic under the Right to Choose pathway. Demonstrating knowledge of this option shows examiners you understand patient choice within the NHS framework.

How do I balance harm reduction with my prescribing responsibilities?

The GMC and RCGP guidance is clear: a harm reduction approach is appropriate when a patient is already using unregulated hormones. This means monitoring their health rather than refusing to engage until they stop. You are not being asked to prescribe testosterone — you are being asked to arrange safety blood tests, provide harm reduction advice, and initiate a GIC referral. Framing this as patient safety rather than endorsement helps structure your approach.

How is this case different from other sensitive issue consultations?

Unlike most sensitive issue cases, this consultation combines identity affirmation with a genuine clinical safety emergency. The self-administered testosterone creates an urgency that bereavement or relationship counselling cases typically lack. You must simultaneously build trust (through identity affirmation) and act on a medical concern (unmonitored hormone use) — these two goals can feel contradictory but must be integrated seamlessly.